Literature DB >> 19557503

Egr-1 upregulates OPN through direct binding to its promoter and OPN upregulates Egr-1 via the ERK pathway.

Qi-Feng Liu1, Hong-Wei Yu, Gui-Nan Liu.   

Abstract

Early growth response factor-1 (Egr-1) and osteopontin (OPN) play important roles in the migration and proliferation of vascular smooth muscle cells (VSMC), but little is known about their relationship. Therefore, we transfected VSMCs with either Egr-1 cDNA, Opn cDNA, a DNA enzyme designed to target Egr-1 (ED5), or antisense Opn oligodeoxynucleotides and examined changes in Egr-1 and OPN expression at the mRNA and protein levels. OPN expression levels were increased in cells that were stably transfected with Egr-1 cDNA. By contrast, both Egr-1 and OPN expression were reduced when ED5 was transfected into Egr-1-expressing cells. Similarly, Opn transfection upregulated Egr-1 levels, while Opn anti-sense oligodeoxynucleotide transfection decreased Egr-1 expression. ChIP analysis showed that Egr-1 binds to the Opn gene promoter. Furthermore, treatment with the extracellular-regulated protein kinase (ERK) inhibitor PD98059 inhibited the upregulation of Egr-1 by OPN. We find that Egr-1 and OPN positively regulate each other in VSMCs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19557503     DOI: 10.1007/s11010-009-0176-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  37 in total

1.  Influence of sustained mechanical stress on Egr-1 mRNA expression in cultured human endothelial cells.

Authors:  M Stula; H D Orzechowski; S Gschwend; R Vetter; R von Harsdorf; R Dietz; M Paul
Journal:  Mol Cell Biochem       Date:  2000-07       Impact factor: 3.396

2.  Suppression of growth factor expression and human vascular smooth muscle cell growth by small interfering RNA targeting EGR-1.

Authors:  Roger G Fahmy; Levon M Khachigian
Journal:  J Cell Biochem       Date:  2007-04-15       Impact factor: 4.429

3.  Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-beta type II receptor.

Authors:  B Du; C Fu; K C Kent; H Bush; A H Schulick; K Kreiger; T Collins; T A McCaffrey
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

4.  Effects of N-n-butyl haloperidol iodide on myocardial ischemia/reperfusion injury and Egr-1 expression in rat.

Authors:  Yan-Mei Zhang; Gang-Gang Shi; Zhao Tang; Jin-Hong Zheng; Wei-Qiu Li; Fu-Xiao Guo; Qiang-Yong Jia
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2006-06       Impact factor: 3.848

5.  P38 MAPK inhibitors suppress biomarkers of hypertension end-organ damage, osteopontin and plasminogen activator inhibitor-1.

Authors:  S S Nerurkar; A R Olzinski; K S Frazier; R C Mirabile; S P O'Brien; J Jing; D Rajagopalan; T L Yue; R N Willette
Journal:  Biomarkers       Date:  2007 Jan-Feb       Impact factor: 2.658

6.  Evidence of EGR1 as a differentially expressed gene among proliferative skin diseases.

Authors:  Min Fang; Sue Ann Wee; Karyn Ronski; Hongran Fan; Shiying Tao; Qun Lin
Journal:  Genomic Med       Date:  2007-07-25

Review 7.  Osteopontin: a protein with diverse functions.

Authors:  D T Denhardt; X Guo
Journal:  FASEB J       Date:  1993-12       Impact factor: 5.191

8.  Sp1 regulates osteopontin expression in SW480 human colon adenocarcinoma cells.

Authors:  Yoji Takami; Michael B Russell; Chengjiang Gao; Zhiyong Mi; Hongtao Guo; Christopher R Mantyh; Paul C Kuo
Journal:  Surgery       Date:  2007-08       Impact factor: 3.982

9.  Multilineage differentiation of adipose-derived stromal cells from GFP transgenic mice.

Authors:  Yunfeng Lin; Xizhe Chen; Zhengbin Yan; Lei Liu; Wei Tang; Xiaohui Zheng; Zhiyong Li; Ju Qiao; Shengwei Li; Weidong Tian
Journal:  Mol Cell Biochem       Date:  2006-02-14       Impact factor: 3.396

10.  Transfected synthetic DNA enzyme gene specifically inhibits Egr-1 gene expression and reduces neointimal hyperplasia following balloon injury in rats.

Authors:  Gui-Nan Liu; Ya-Xuan Teng; Wu Yan
Journal:  Int J Cardiol       Date:  2008-02-01       Impact factor: 4.164

View more
  5 in total

1.  ERK1 and ERK2 regulate chondrocyte terminal differentiation during endochondral bone formation.

Authors:  Zhijun Chen; Susan X Yue; Guang Zhou; Edward M Greenfield; Shunichi Murakami
Journal:  J Bone Miner Res       Date:  2015-05       Impact factor: 6.741

2.  Prevention of neointimal hyperplasia in balloon-injured rat carotid artery via small interference RNA mediated downregulation of osteopontin gene.

Authors:  Jian Xu; Yingxian Sun; Tairan Wang; Guinan Liu
Journal:  Mol Cell Biochem       Date:  2013-03-07       Impact factor: 3.396

3.  Expression of high-mobility groups box-1/receptor for advanced glycation end products/osteopontin/early growth response-1 pathway in proliferative vitreoretinal epiretinal membranes.

Authors:  Ahmed M Abu El-Asrar; Luc Missotten; Karel Geboes
Journal:  Mol Vis       Date:  2011-02-17       Impact factor: 2.367

4.  Platelet-derived growth factor induces Rad expression through Egr-1 in vascular smooth muscle cells.

Authors:  Yan Luo; Meiling Zhang; Ji Zhang; Jifeng Zhang; Chunlei Chen; Y Eugene Chen; Jing-Wei Xiong; Xiaojun Zhu
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

5.  Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer.

Authors:  Yin-Hsun Feng; Yu-Chu Su; Shuo-Fu Lin; Pey-Ru Lin; Chao-Liang Wu; Chao-Ling Tung; Chien-Feng Li; Gia-Shing Shieh; Ai-Li Shiau
Journal:  BMC Cancer       Date:  2019-08-09       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.